Glytec: Funding, Investors & Team (Oct 2026)
Glytec is a personalized digital therapeutics company that specializes in inpatient and outpatient insulin management. Their FDA-cleared software-as-a-medical-device solutions improve the safety and well-being of individuals with diabetes by making insulin a more effective treatment option. By combining evidence-based decision support technologies with expert clinical services, Glytec optimizes basal and bolus insulin therapies in both hospital and home settings, resulting in decreased hypoglycemia and complications, as well as reducing the need for ED visits, hospitalizations, readmissions, and medication waste. Glytec has locations in Waltham, Massachusetts, and Greenville, South Carolina.
Glytec has raised $36.0M across 1 funding round on record, the most recent an undisclosed round of $36.0M announced in Jun 2025.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Glytec Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Glytec Funding Rounds
Glytec Founders and Leadership Team
No contact details are on record for this team yet.
Glytec Funding Compared to Other Health Care Startups
Glytec's latest round of $36.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Glytec in Health Care and Greenville
Companies Similar to Glytec
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Glytec Funding FAQs
What does Glytec do?
Glytec is a personalized digital therapeutics company that specializes in inpatient and outpatient insulin management. Their FDA-cleared software-as-a-medical-device solutions improve the safety and well-being of individuals with diabetes by making insulin a more effective treatment option. By combining evidence-based decision support technologies with expert clinical services, Glytec optimizes basal and bolus insulin therapies in both hospital and home settings, resulting in decreased hypoglycemia and complications, as well as reducing the need for ED visits, hospitalizations, readmissions, and medication waste. Glytec has locations in Waltham, Massachusetts, and Greenville, South Carolina.
How much funding has Glytec raised?
Glytec has raised $36.0M across 1 round on record. The most recent is an undisclosed round of $36.0M announced in Jun 2025.
When did Glytec last raise funding?
Glytec's most recent funding round on record is an undisclosed round of $36.0M, announced in Jun 2025.
Who founded Glytec?
FundedIQ lists Bruce Bode (Founder) at Glytec.
Where is Glytec headquartered?
Glytec is based in Greenville, South Carolina, United States.
How many employees does Glytec have?
Glytec is in the 51-100 employee band.
How does Glytec's funding compare to other Health Care startups?
Glytec's latest round of $36.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Glytec Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Glytec is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.